Moneycontrol PRO
Outskill Genai
HomeNewsBusinessCryptocurrencyLack of COVID-19 data from China biggest worry for Centre

Lack of COVID-19 data from China biggest worry for Centre

Huge discrepancy between the real situation in China and what is projected outside. Senior government functionaries said the trend in cases over the next few weeks is going to be extremely crucial.

December 26, 2022 / 14:57 IST
Under China's new definition of Covid deaths, only those who die of respiratory failure -- and not pre-existing conditions exacerbated by the virus -- are counted. That means many of the dead in Chongqing -- and across the country -- are no longer registered as coronavirus victims. (Image: AFP)

Though the COVID-19 situation in India stays stable, the biggest worry for the government, as of now, is the lack of clear and detailed data from China.

The reports from China mostly suggest that Omicron BF.7 variant is driving the surge in the country and the Centre says that genomic surveillance is going to be a crucial tool in determining the trajectory of the pandemic here too.

“Though the two COVID-19 sub-variants thought to be behind the latest surge in China— Omicron BF.7 and Omicron XBB—have been present in India for a long time, we still feel the need to step up our guard as China is not sharing the details officially,” said a senior official in the Union health ministry.

Another official in the public health section of the ministry pointed out that China’s record of censorship is a major blind spot for the world as countries prepare to navigate another potential wave of the infection amid the alarming situation in China where the pandemic originally began three years ago.

“Even if daily COVID-19 data is shared in China, there is a huge discrepancy between the reality and what is projected outside and therefore we have to stay extremely cautious,” he added. “That’s why we need to be vigilant for the next several weeks and the picture will be clear only by mid-January.”

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

According to government sources, while four cases of Omicron BF.7 have been detected in India so far, with the first one detected as early as July this year, XBB remains one of the most dominant SARS CoV 2 viruses in the country at present.

A scientist attached with India’s COVID-19 genomic surveillance programme meanwhile pointed out that even though BF.7 has been in India for the last several months, it has not grown with respect to XBB, which is the dominant variant now.

“I do not see a reason for India to worry as of now but paying attention to surveillance on SARS CoV 2 variants arriving in India and circulating here are very important,” the scientist said.

India’s COVID-19 situation

In the last 24 hours, a total of 156 new coronavirus cases were recorded in the country while the number of active cases stood at 3,428, as on December 26.

Also read: Exclusive: States make desperate demands for more COVID-19 vaccines, Centre faces a stockout

The rolling average of the weekly COVID-19 test positivity rate also stayed low at 0.16 percent, as per the figures shared by the government. Also, 13 states and Union Territories in India did not have a single active case on December 26.

Figures also showed a week-on-week decline in the positivity rate over the last several months.

On its part, the Centre has begun random screening of 2 percent of international passengers on every flight from December 24. The samples of all the passengers testing COVID-19 positive are then subjected to whole genome sequencing.

There will be a nationwide mock drill across all health facilities on December 27 to ensure operational readiness of COVID-19 dedicated facilities with a specific focus on oxygen plants, ventilators, logistics and human resources.

In addition, the government said it has also enhanced surveillance across the state to step up health facility-based sentinel, pan-respiratory virus, community-based and sewage or wastewater surveillance.

Sumi Sukanya Dutta
Sumi Sukanya Dutta
first published: Dec 26, 2022 02:57 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347